Head & neck: Early glottic cancer — radical radiotherapy fractionation
Free question published 29 October 2026
A 68-year-old man with a T1a N0 squamous cell carcinoma confined to the right true vocal cord with normal cord mobility is to be treated with radical radiotherapy aiming to preserve voice. He declines transoral laser surgery. What is the most appropriate radiotherapy approach for this early glottic cancer in UK practice?
- ALarge-field radiotherapy electively covering bilateral neck nodal levels II-IV to 60 Gy
- BInduction chemotherapy followed by radiotherapy
- CConventional 70 Gy in 35 fractions to the larynx with elective nodal irradiation
- DConcurrent cisplatin chemoradiotherapy to 70 Gy in 35 fractions
- EA small-volume larynx-only field using a moderately hypofractionated radical schedule such as 53 Gy in 16 fractions or 50-52.5 Gy in 16-20 fractions
Why E is correct
Early (T1-T2 N0) glottic cancer has a very low rate of nodal involvement, so radiotherapy is delivered to a small larynx-only volume without elective nodal irradiation, using a hypofractionated radical schedule. UK practice uses regimens such as 53 Gy in 16 fractions or similar, which give excellent local control and voice preservation; concurrent chemotherapy is not indicated for T1 disease.
And why the others are not
- AWrong — elective nodal irradiation is unnecessary because early glottic tumours rarely involve nodes, and it adds toxicity.
- BWrong — induction chemotherapy has no role in early glottic cancer.
- CWrong — elective nodal coverage is not required and a small larynx-only volume is preferred.
- DWrong — concurrent chemoradiotherapy is reserved for locally advanced disease, not T1a glottic cancer.
Source Definitive hypofractionated radiotherapy for early glottic carcinoma — 55 Gy in 20 fractions — Ermiş E, Teo M, Dyker KE, et al. Radiat Oncol 2015;10:203. PMID 26395876.
More free head & neck questions
- Head & neck: Oropharynx de-escalation — RTOG 1016 locoregional control · 18 October 2026
- Head & neck: Salivary gland — postoperative radiotherapy indications · 09 November 2026
- Head & neck: Oropharynx — definitive chemoRT and altered fractionation · 07 October 2026
Sitting in February? Follow the twenty-week plan.
2,500+ cited questions like this one are waiting in the vault.
See plans and pricing